https://scholars.lib.ntu.edu.tw/handle/123456789/192345
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor | 外科 | en |
dc.contributor.author | WANG, SHOEI-SHEN | en |
dc.contributor.author | CHOU, NAI-KUAN | en |
dc.contributor.author | KO, WEN-JE | en |
dc.contributor.author | YU, HSI-YU | en |
dc.contributor.author | CHEN, YIH-SHARNG | en |
dc.contributor.author | HSU, RON-BIN | en |
dc.contributor.author | HUANG, SONG-CHEI | en |
dc.contributor.author | CHI, NAI-HSIN | en |
dc.contributor.author | TSAO, CHUAN-I | en |
dc.contributor.author | LAI, MING-YANG | en |
dc.contributor.author | LIAU, CHIAU-SUONG | en |
dc.contributor.author | LEE, YUAN-THE | en |
dc.creator | 王水深;周迺寬;柯文哲;虞希禹;陳益祥;許榮彬;黃嵩雀;紀乃新;曹傳怡;賴明陽;廖朝崧;李源德 | zh_TW |
dc.creator | WANG, SHOEI-SHEN;CHOU, NAI-KUAN;KO, WEN-JE;YU, HSI-YU;CHEN, YIH-SHARNG;HSU, RON-BIN;HUANG, SONG-CHEI;CHI, NAI-HSIN;TSAO, CHUAN-I;LAI, MING-YANG;LIAU, CHIAU-SUONG;LEE, YUAN-THE | en |
dc.date | 2004 | en |
dc.date.accessioned | 2008-12-16T01:08:13Z | - |
dc.date.accessioned | 2018-07-11T09:27:09Z | - |
dc.date.available | 2008-12-16T01:08:13Z | - |
dc.date.available | 2018-07-11T09:27:09Z | - |
dc.date.issued | 2004 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/91965 | - |
dc.description.abstract | From May 1994 to September 2003, 177 hearts were procured for heart transplantation (HTx) from donors ranging in age from 1 year 2 months to 66 years 5 months (mean = 30 years). All donors and recipients received serologic tests for hepatitis B surface antigen (HBsAg) and antibody (anti -HBs), and hepatitis C virus antibody (anti-HCV). Thirty-two donors were HBsAg-positive and another four were anti-HCV- positive. Two HBsAg- positive donors were transplanted to patients with no previous evidence of hepatitis. After HTx, one received hepatitis B immunoglobulin prophylaxis and no hepatitis was noted during a 5 years follow-up. The other seroconverted at 4 months after HTx, requiring lamivudine treatment. Another four HBsAg-positive donors were transplanted to HBsAg-positive recipients. All four recipients had hepatitis flare-ups requiring lamivudine treatment. The other 26 HBsAg-positive donors were transplanted to anti-HBs-positive recipients. None suffered from hepatitis. Among the four patients receiving anti-HCV- positive hearts, seroconversion was noted in one recipient at 26 months. This patient never had clinical hepatitis before he died of allograft rejection at 3 years after HTx. The other three recipients remain anti-HCV negative during follow-up of 80, 50 , and 46 months. It was concluded the hepatitis B- or C-positive donors could be used as heart donors for status 1 patients. Donors with positive HBsAg may be transplanted to anti-HBs-positive recipients with no HBV infection. | en |
dc.language | en-us | en |
dc.language.iso | en_US | - |
dc.relation | TRANSPLANTATION PROCEEDINGS v.36 n.8 pp.2371-2373 | en |
dc.relation.ispartof | TRANSPLANTATION PROCEEDINGS | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | Heart Transplantation Using Donors Positive for Hepatitis | en |
dc.type | journal article | en |
dc.relation.pages | 2371-2373 | - |
dc.relation.journalvolume | v.36 | - |
dc.relation.journalissue | n.8 | - |
item.openairetype | journal article | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en_US | - |
item.cerifentitytype | Publications | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。